Skip to main content
. 2021 Mar 24;124(11):1795–1802. doi: 10.1038/s41416-021-01284-2

Fig. 1. Consort diagram: ABCSG-34 trial overview.

Fig. 1

ITT intent-to-treat, SoC Standard-of-Care, AI aromatase inhibitor.